Glycosaminoglycans and Sialylated Glycans Sequentially Facilitate Merkel Cell Polyomavirus Infectious Entry
2011

How Merkel Cell Polyomavirus Enters Cells

publication Evidence: moderate

Author Information

Author(s): Rachel M. Schowalter, Diana V. Pastrana, Christopher B. Buck, Michael Imperiale

Primary Institution: National Cancer Institute, Bethesda, Maryland, United States of America

Hypothesis

What cellular receptors or co-receptors are required for the infectious entry of Merkel cell polyomavirus (MCV)?

Conclusion

MCV primarily uses glycosaminoglycans, particularly heparan sulfate, for initial attachment to cells, while sialylated glycans play a secondary role in the entry process.

Supporting Evidence

  • MCV does not require sialic acid-bearing glycans for initial attachment to cells.
  • Glycosaminoglycans, particularly heparan sulfate, are essential for MCV infectious entry.
  • Sialylated glycans may act as a co-factor after MCV has attached to the cell.
  • MCV capsids can bind to cells deficient in sialylated glycans but are resistant to transduction.
  • Chondroitin sulfate was found to be a more effective inhibitor of MCV transduction than heparin.

Takeaway

MCV, a virus linked to skin cancer, attaches to cells using special sugars called glycosaminoglycans, and needs another type of sugar for the next step to enter the cell.

Methodology

The study used cultured human cell lines to investigate the binding and entry mechanisms of MCV using reporter vectors and various glycosaminoglycan treatments.

Limitations

The study primarily focused on cultured cell lines, which may not fully represent in vivo conditions.

Digital Object Identifier (DOI)

10.1371/journal.ppat.1002161

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication